[1]
|
苟云久, 于珺, 何晓东, 谢定雄, 赵静. 肺癌与血清甲状腺激素水平关系的Meta分析[J]. 临床荟萃, 2014, 29(12): 1355-1361.
|
[2]
|
高士豪, 王章站. 电视胸腔镜手术与传统手术相比治疗非小细胞肺癌患者对其心肺功能的影响[J]. 健康大视野, 2020(1): 58-59.
|
[3]
|
刘艳琰. 非小细胞肺癌患者化疗前后血清甲状腺激素水平变化分析[J]. 中国实用医刊, 2015, 42(7): 117-118.
|
[4]
|
葛均波, 徐永健. 内科学[M]. 第8版. 北京: 人民卫生出版社, 2014.
|
[5]
|
朱大年, 王庭槐. 生理学[M]. 第8版. 北京: 人民卫生出版社, 2013.
|
[6]
|
Gonzalez-Sancho, J.M., García, V., Bonilla, F., et al. (2003) Thyroid Hormone Receptors/THR Genes in Human Cancer. Cancer Letters, 192, 121-132. https://doi.org/10.1016/S0304-3835(02)00614-6
|
[7]
|
Aranda, A., Martínez-Iglesias, O., Ruiz-Llorente, L., et al. (2009) Thyroid Receptor: Roles in Cancer. Trends in Endocrinology and Metabolism, 20, 318-324. https://doi.org/10.1016/j.tem.2009.03.011
|
[8]
|
Bailey, E.B.,Tantravahi, S.K., Poole, A., et al. (2015) Correlation of Degree of Hypothyroidism with Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors. Clinical Genitourinary Cancer, 13, 131-137. https://doi.org/10.1016/j.clgc.2014.11.002
|
[9]
|
Hellevik, A.I., Asvold, B.O., Bj?ro, T., et al. (2009) Thyroid Function and Cancer Risk: A Prospective Population Study. Cancer Epidemiology, Biomarkers & Prevention, 18, 570-574. https://doi.org/10.1158/1055-9965.EPI-08-0911
|
[10]
|
Mazzoccoli, G., Pazienza, V., Piepoli, A., et al. (2012) Al-teration of Hypothalamic-Pituitary-Thyroid Axis Function in Non-Small-Cell Lung Cancer Patients. Integrative Cancer Therapies, 11, 327-336. https://doi.org/10.1177/1534735411413269
|
[11]
|
Cabodi, S., del Pilar Camacho-Leal, M., Di Stefano, P., et al. (2010) Integrin Signalling Adaptors: Not Only Figurants in the Cancer Story. Nature Reviews. Cancer, 10, 858-870. https://doi.org/10.1038/nrc2967
|
[12]
|
Desgrosellier, J.S. and Cheresh, D.A. (2010) Integrins in Cancer: Biological Implications and Therapeutic Opportunities. Nature Reviews. Cancer, 10, 9-22. https://doi.org/10.1038/nrc2748
|
[13]
|
Belmadani, S., Zerfaoui, M., Boulares, H.A., et al. (2008) Microvessel Vascular Smooth Muscle Cells Contribute to Collagen Type I Deposition through ERK1/2 MAP Kinase, Alpha V Be-ta3-Integrin, and TGF-Beta1 in Response to ANG II and High Glucose. American Journal of Physiology. Heart and Circulatory Physiology, 295, 69-76. https://doi.org/10.1152/ajpheart.00341.2008
|
[14]
|
Cai, W. and Chen, X. (2006) Anti-Angiogenic Cancer Therapy Based on Integrin Alpha v Beta3 Antagonism. Anti-Cancer Agents in Medicinal Chemistry, 6, 407-428. https://doi.org/10.2174/187152006778226530
|
[15]
|
Arnaout, M.A., Goodman, S.L. and Xiong, J.P. (2007) Struc-ture and Mechanics of Integrin-Based Cell Adhesion. Current Opinion in Cell Biology, 19, 495-507. https://doi.org/10.1016/j.ceb.2007.08.002
|
[16]
|
Byzova, T.V., Goldman, C.K., Pampori, N., et al. (2000) A Mechanism for Modulation of Cellular Responses to VEGF: Activation of the Integrins. Molecular Cell, 6, 851-860. https://doi.org/10.1016/S1097-2765(00)00083-6
|
[17]
|
Bergh, J.J., Lin, H.Y., Lansing, L., et al. (2005) Integrin aVb3 Contains a Cell Surface Receptor Site for Thyroid Hormone that Is Linked to Activation of Mitogen-Activated Protein Kinase and Induction of Angiogenesis. Endocrinology, 146, 2864-2871. https://doi.org/10.1210/en.2005-0102
|
[18]
|
Meng, R., Tang, H.Y., Westfall, J., et al. (2011) Crosstalk between Integrin αvβ3 and Estrogen Receptor-α Is Involved in Thyroid Hormone-Induced Proliferation in Human Lung Carci-noma Cells. PLoS ONE, 6, 27547. https://doi.org/10.1371/journal.pone.0027547
|
[19]
|
Davis, P.J., Davis, F.B., Mousa, S.A., et al. (2011) Membrane Receptor for Thyroid Hormone: Physiologic and Pharmacologic Implications. Annual Review of Pharmacology and Toxicology, 51, 99-115. https://doi.org/10.1146/annurev-pharmtox-010510-100512
|
[20]
|
Moeller, L.C., Dumitrescu, A.M. and Refetoff, S. (2005) Cytosolic Action of Thyroid Hormone Leads to Induction of Hypoxia-Inducible Factor-1α and Glycolytic Genes. Molecular Endocrinology, 19, 2955-2963. https://doi.org/10.1210/me.2004-0542
|
[21]
|
Lin, H.Y., Sun, M., Tang, H.Y., et al. (2009) L-Thyroxine vs. 3,5,3’-Triiodo-L-Thyronine and Cell Proliferation: Activation of Mitogen-Activated Protein Kinase and Phosphatidyl-inositol 3-Kinase. American Journal of Physiology. Cell Physiology, 296, C980-C991. https://doi.org/10.1152/ajpcell.00305.2008
|
[22]
|
Moeller, L.C. and Führer, D. (2013) Thyroid Hormone, Thyroid Hormone Receptors, and Cancer: A Clinical Perspective. Endocrine-Related Cancer, 20, 19-29. https://doi.org/10.1530/ERC-12-0219
|
[23]
|
Lin, H.Y., Su, Y.F., Hsieh, M.T., et al. (2013) Nuclear Monomeric Integrin αv in Cancer Cells Is a Coactivator Regulated by Thyroid Hormone. The FASEB Journal, 27, 3209-3216. https://doi.org/10.1096/fj.12-227132
|
[24]
|
Lin, H.Y., Cody, V., Davis, F.B., et al. (2011) Identification and Functions of the Plasma Membrane Receptor for Thyroid Hormone Analogues. Discovery Medicine, 11, 337-347.
|
[25]
|
Cody, V., Davis, P.J. and Davis, F.B. (2007) Molecular Modeling of the Thyroid Hormone Interactions with Alpha v Beta 3 Integrin. Steroids, 72, 165-170. https://doi.org/10.1016/j.steroids.2006.11.008
|
[26]
|
Kress, E., Samarut, J. and Plateroti, M. (2009) Thyroid Hormones and the Control of Cell Proliferation or Cell Differentiation: Paradox or Duality? Molecular and Cellular Endocrinology, 313, 36-49. https://doi.org/10.1016/j.mce.2009.08.028
|
[27]
|
Lin, H.Y., Chin, Y.T., Nana, A.W., et al. (2016) Actions Oef l-Thyroxine and Nano-Diamino-Tetrac (Nanotetrac) on PD-L1 in Cancer Cells. Steroids, 114, 59-67. https://doi.org/10.1016/j.steroids.2016.05.006
|
[28]
|
Lin, H.Y., Glinsky, G.V., Mousa, S.A., et al. (2015) Thyroid Hormone and Anti-Apoptosis in Tumor Cells. Oncotarget, 6, 14735-14743. https://doi.org/10.18632/oncotarget.4023
|
[29]
|
Mazzoccoli, G., Pazienza, V., Piepoli, A., et al. (2012) Alteration of Hypothalamic-Pituitay-Thyroid Axis Function in Non-Small Cell Lung Cancer Patients. Integrative Cancer Therapies, 11, 327-336. https://doi.org/10.1177/1534735411413269
|
[30]
|
薛荣梅, 葛伟. 肺癌患者血清甲状腺激素的变化及临床意义[J]. 现代肿瘤医学, 2015, 23(8): 1081-1083.
|
[31]
|
李红燕, 王少芳, 王龙. 非小细胞肺癌患者化疗前后血清甲状腺激素水平的变化[J]. 中国临床研究, 2015, 28(9): 1131-1134.
|
[32]
|
王长江, 许卫国. 甲状腺激素与N末端脑钠肽前体对非小细胞肺癌的诊断价值[J]. 国际检验医学杂志, 2019, 40(17): 2107-2111.
|
[33]
|
Chopra, I.J. (1997) Clinical Review 86 Euthyroid Sick Syndrome: Is It a Misnomer? The Journal of Clinical Endocrinology and Metabolism, 82, 329-334. https://doi.org/10.1210/jcem.82.2.3745
|
[34]
|
Moeller, L.C. and Führer, D. (2013) Thyroid Hormone, Thyroid Hormone Receptors, and Cancer: A Clinical Perspective. Endocrine-Related Cancer, 20, 19-29. https://doi.org/10.1530/ERC-12-0219
|
[35]
|
Garfield, D.H., Wolter, P., Sch?ffski, P., et al. (2008) Documentation of Thyroid Function in Clinical Studies with Sunitinib: Why Does It Matter. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 26, 5131-5132. https://doi.org/10.1200/JCO.2008.18.8680
|
[36]
|
Khan Samer, R., Layal, C., Rikje, R., et al. (2016) Thyroid Function and Cancer Risk: The Rotterdam Study. The Journal of Clinical Endocrinology and Metabolism, 101, 5030-5036. https://doi.org/10.1210/jc.2016-2104
|